Antibiotics Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2017 to 2021 and Forecast 2022 to 2028

$ PRICE - $ 3,000.00$ 8,900.00

Antibiotics Market: By Drug Class (Cephalosporins, Penicillins, Fluroquinilones, Macrolides, Carbapenems, Aminoglycosides, Sulfonamides, Others), By Action Mechanism (Cell Wall Synthesis Inhibitors, Protein Synthesis Inhibitors, DNA Synthesis Inhibitors, RNA Synthesis Inhibitors, Mycolic Acid Inhibitors, Others), By Spectrum (Broad-spectrum Antibiotics, Narrow-spectrum Antibiotics), and Geography

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail
SKU: N/A Categories: ,

Report

Description

1. Executive Summary
2. Global Antibiotics Market Introduction
2.1. Global Antibiotics Market – Taxonomy
2.2. Global Antibiotics Market –Definitions
2.2.1. By Drug Class
2.2.2. By Action Mechanism
2.2.3. By Spectrum
2.2.4. By Region
3. Global Antibiotics Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Antibiotics Market Dynamic Factors – Impact Analysis
3.6. Global Antibiotics Market – Competition Landscape
4. Global Antibiotics Market Analysis,2017-2021 and Forecast, 2022-2028
4.1. Market Analysis,2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. Global Antibiotics Market, By Drug Class, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.1. Cephalosporins
5.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Penicillins
5.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Fluroquinilones
5.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
5.4. Macrolides
5.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.4.3. Market Opportunity Analysis
5.5. Carbapenems
5.5.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.5.3. Market Opportunity Analysis
5.6. Aminoglycosides
5.6.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.6.3. Market Opportunity Analysis
5.7. Sulfonamides
5.7.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.7.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
Market Opportunity Analysis
5.8. Others
5.8.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.8.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.8.3. Market Opportunity Analysis
6. Global Antibiotics Market Forecast, By Action Mechanism, 2017-2021 and Forecast, 2021 – 2027 (Revenue, USD Mn)
6.1. Cell Wall Synthesis Inhibitors
6.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Protein Synthesis Inhibitors
6.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. DNA Synthesis Inhibitors
6.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
6.4. RNA Synthesis Inhibitors
6.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.4.3. Market Opportunity Analysis
6.5. Mycolic Acid Inhibitors
6.5.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.5.3. Market Opportunity Analysis
6.6. Others
6.6.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.6.3. Market Opportunity Analysis
7. Global Antibiotics Market, By Spectrum, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.1. Broad-spectrum Antibiotics
7.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Narrow-spectrum Antibiotics
7.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
8. Global Antibiotics Market Forecast, By Region, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.1. North America
8.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Europe
8.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Asia-Pacific
8.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
8.4. Latin America
8.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.4.3. Market Opportunity Analysis
8.5. Middle East and Africa
8.5.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.5.3. Market Opportunity Analysis
8.6. Global Antibiotics Market – Opportunity Analysis Index, By Drug Class, Action Mechanism, Spectrum, and Region, 2022-2028
9. North America Antibiotics MarketAnalysis,2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
9.1. By Drug Class Analysis 2017-2021 and Forecast 2022-2028by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
9.1.1. Cephalosporins
9.1.2. Penicillins
9.1.3. Fluroquinilones
9.1.4. Macrolides
9.1.5. Carbapenems
9.1.6. Aminoglycosides
9.1.7. Sulfonamides
9.1.8. Others
9.2. Action Mechanism Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
9.2.1. Cell Wall Synthesis Inhibitors
9.2.2. Protein Synthesis Inhibitors
9.2.3. DNA Synthesis Inhibitors
9.2.4. RNA Synthesis Inhibitors
9.2.5. Mycolic Acid Inhibitors
9.2.6. Others
9.3. Spectrum Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
9.3.1. Broad-spectrum Antibiotics
9.3.2. Narrow-spectrum Antibiotics
9.4. Country Analysis 2017-2021 and Forecast 2022-2028by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
9.4.1. USA
9.4.2. Canada
9.5. North America Antibiotics Market – Opportunity Analysis Index, By  Drug Class, Action Mechanism, Spectrum, and Country, 2022-2028
9.6. North America Antibiotics Market Dynamics – Trends
10. Europe Antibiotics Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
10.1. By Drug Class Analysis 2017-2021 and Forecast 2022-2028by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
10.1.1. Cephalosporins
10.1.2. Penicillins
10.1.3. Fluroquinilones
10.1.4. Macrolides
10.1.5. Carbapenems
10.1.6. Aminoglycosides
10.1.7. Sulfonamides
10.1.8. Others
10.2. Action Mechanism Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.2.1. Cell Wall Synthesis Inhibitors
10.2.2. Protein Synthesis Inhibitors
10.2.3. DNA Synthesis Inhibitors
10.2.4. RNA Synthesis Inhibitors
10.2.5. Mycolic Acid Inhibitors
10.2.6. Others
10.3. Spectrum Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.3.1. Broad-spectrum Antibiotics
10.3.2. Narrow-spectrum Antibiotics
10.4. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.4.1. Germany
10.4.2. UK
10.4.3. France
10.4.4. Spain
10.4.5. Italy
10.4.6. Russia
10.4.7. Poland
10.4.8. Rest of Europe
10.5. Europe Antibiotics Market – Opportunity Analysis Index, By  Drug Class, Action Mechanism, Spectrum, and Country, 2022-2028
10.6. Europe Antibiotics Market Dynamics – Trends
11. Asia-Pacific Antibiotics Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
11.1. By Drug Class Analysis 2017-2021 and Forecast 2022-2028by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
11.1.1. Cephalosporins
11.1.2. Penicillins
11.1.3. Fluroquinilones
11.1.4. Macrolides
11.1.5. Carbapenems
11.1.6. Aminoglycosides
11.1.7. Sulfonamides
11.1.8. Others
11.2. Action Mechanism Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.2.1. Cell Wall Synthesis Inhibitors
11.2.2. Protein Synthesis Inhibitors
11.2.3. DNA Synthesis Inhibitors
11.2.4. RNA Synthesis Inhibitors
11.2.5. Mycolic Acid Inhibitors
11.2.6. Others
11.3. Spectrum Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.3.1. Broad-spectrum Antibiotics
11.3.2. Narrow-spectrum Antibiotics
11.4. Country Analysis2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
11.4.1. Japan
11.4.2. China
11.4.3. India
11.4.4. ASEAN
11.4.5. Australia & New Zealand
11.4.6. Rest of Asia-Pacific
11.5. Asia-Pacific Antibiotics Market – Opportunity Analysis Index, By  Drug Class, Action Mechanism, Spectrum, and Country, 2022-2028
11.6. Asia-Pacific Antibiotics Market Dynamics – Trends
12. Latin America Antibiotics Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
12.1. By Drug Class Analysis 2017-2021 and Forecast 2022-2028by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
12.1.1. Cephalosporins
12.1.2. Penicillins
12.1.3. Fluroquinilones
12.1.4. Macrolides
12.1.5. Carbapenems
12.1.6. Aminoglycosides
12.1.7. Sulfonamides
12.1.8. Others
12.2. Action Mechanism Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.2.1. Cell Wall Synthesis Inhibitors
12.2.2. Protein Synthesis Inhibitors
12.2.3. DNA Synthesis Inhibitors
12.2.4. RNA Synthesis Inhibitors
12.2.5. Mycolic Acid Inhibitors
12.2.6. Others
12.3. Spectrum Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.3.1. Broad-spectrum Antibiotics
12.3.2. Narrow-spectrum Antibiotics
12.4. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Argentina
12.4.4. Rest of Latin America
12.5. Latin America Antibiotics Market – Opportunity Analysis Index, By  Drug Class, Action Mechanism, Spectrum, and Country, 2022-2028
12.6. Latin America Antibiotics Market Dynamics – Trends
13. Middle East and Africa Antibiotics Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
13.1. By Drug Class Analysis 2017-2021 and Forecast 2022-2028by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
13.1.1. Cephalosporins
13.1.2. Penicillins
13.1.3. Fluroquinilones
13.1.4. Macrolides
13.1.5. Carbapenems
13.1.6. Aminoglycosides
13.1.7. Sulfonamides
13.1.8. Others
13.2. Action Mechanism Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.2.1. Cell Wall Synthesis Inhibitors
13.2.2. Protein Synthesis Inhibitors
13.2.3. DNA Synthesis Inhibitors
13.2.4. RNA Synthesis Inhibitors
13.2.5. Mycolic Acid Inhibitors
13.2.6. Others
13.3. Spectrum Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.3.1. Broad-spectrum Antibiotics
13.3.2. Narrow-spectrum Antibiotics
13.4. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
13.4.1. Gulf Cooperation Council (GCC) Countries
13.4.2. Israel
13.4.3. South Africa
13.4.4. Rest of MEA
13.5. MEA Antibiotics Market – Opportunity Analysis Index, By  Drug Class, Action Mechanism, Spectrum, and Country, 2022-2028
13.6. MEA Antibiotics Market Dynamics – Trends
14. Competition Landscape 
14.1. Strategic Dashboard of Top Market Players
14.2. Company Profiles (Introduction, Financial Analysis, Action Mechanism& Service Offerings, Key Developments, Strategies, and SWOT Analysis)
14.2.1. Abbott Laboratories
14.2.2. Allergan Plc.
14.2.3. F. Hoffmann-La Roche Ltd.
14.2.4. GlaxoSmithKline plc
14.2.5. Merck & Co. Inc.
14.2.6. Mylan N.V.
14.2.7. Novartis International AG (Sandoz)
14.2.8. Pfizer Inc.
14.2.9. Sanofi
14.2.10. Teva Pharmaceutical Industries Ltd.
15. Research Methodology
16. Key Assumptions and Acronyms

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.


Report

Company Profile

 

  • Abbott Laboratories
  • Allergan Plc.
  • Hoffmann-La Roche Ltd.
  • GlaxoSmithKline plc
  • Merck & Co. Inc.
  • Mylan N.V.
  • Novartis International AG (Sandoz)
  • fizer Inc.
  • Sanofi
  • Teva Pharmaceutical Industries Ltd.

Description

1. Executive Summary
2. Global Antibiotics Market Introduction
2.1. Global Antibiotics Market – Taxonomy
2.2. Global Antibiotics Market –Definitions
2.2.1. By Drug Class
2.2.2. By Action Mechanism
2.2.3. By Spectrum
2.2.4. By Region
3. Global Antibiotics Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Antibiotics Market Dynamic Factors – Impact Analysis
3.6. Global Antibiotics Market – Competition Landscape
4. Global Antibiotics Market Analysis,2017-2021 and Forecast, 2022-2028
4.1. Market Analysis,2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. Global Antibiotics Market, By Drug Class, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.1. Cephalosporins
5.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Penicillins
5.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Fluroquinilones
5.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
5.4. Macrolides
5.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.4.3. Market Opportunity Analysis
5.5. Carbapenems
5.5.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.5.3. Market Opportunity Analysis
5.6. Aminoglycosides
5.6.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.6.3. Market Opportunity Analysis
5.7. Sulfonamides
5.7.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.7.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
Market Opportunity Analysis
5.8. Others
5.8.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.8.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.8.3. Market Opportunity Analysis
6. Global Antibiotics Market Forecast, By Action Mechanism, 2017-2021 and Forecast, 2021 – 2027 (Revenue, USD Mn)
6.1. Cell Wall Synthesis Inhibitors
6.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Protein Synthesis Inhibitors
6.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. DNA Synthesis Inhibitors
6.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
6.4. RNA Synthesis Inhibitors
6.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.4.3. Market Opportunity Analysis
6.5. Mycolic Acid Inhibitors
6.5.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.5.3. Market Opportunity Analysis
6.6. Others
6.6.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.6.3. Market Opportunity Analysis
7. Global Antibiotics Market, By Spectrum, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.1. Broad-spectrum Antibiotics
7.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Narrow-spectrum Antibiotics
7.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
8. Global Antibiotics Market Forecast, By Region, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.1. North America
8.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Europe
8.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Asia-Pacific
8.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
8.4. Latin America
8.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.4.3. Market Opportunity Analysis
8.5. Middle East and Africa
8.5.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.5.3. Market Opportunity Analysis
8.6. Global Antibiotics Market – Opportunity Analysis Index, By Drug Class, Action Mechanism, Spectrum, and Region, 2022-2028
9. North America Antibiotics MarketAnalysis,2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
9.1. By Drug Class Analysis 2017-2021 and Forecast 2022-2028by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
9.1.1. Cephalosporins
9.1.2. Penicillins
9.1.3. Fluroquinilones
9.1.4. Macrolides
9.1.5. Carbapenems
9.1.6. Aminoglycosides
9.1.7. Sulfonamides
9.1.8. Others
9.2. Action Mechanism Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
9.2.1. Cell Wall Synthesis Inhibitors
9.2.2. Protein Synthesis Inhibitors
9.2.3. DNA Synthesis Inhibitors
9.2.4. RNA Synthesis Inhibitors
9.2.5. Mycolic Acid Inhibitors
9.2.6. Others
9.3. Spectrum Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
9.3.1. Broad-spectrum Antibiotics
9.3.2. Narrow-spectrum Antibiotics
9.4. Country Analysis 2017-2021 and Forecast 2022-2028by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
9.4.1. USA
9.4.2. Canada
9.5. North America Antibiotics Market – Opportunity Analysis Index, By  Drug Class, Action Mechanism, Spectrum, and Country, 2022-2028
9.6. North America Antibiotics Market Dynamics – Trends
10. Europe Antibiotics Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
10.1. By Drug Class Analysis 2017-2021 and Forecast 2022-2028by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
10.1.1. Cephalosporins
10.1.2. Penicillins
10.1.3. Fluroquinilones
10.1.4. Macrolides
10.1.5. Carbapenems
10.1.6. Aminoglycosides
10.1.7. Sulfonamides
10.1.8. Others
10.2. Action Mechanism Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.2.1. Cell Wall Synthesis Inhibitors
10.2.2. Protein Synthesis Inhibitors
10.2.3. DNA Synthesis Inhibitors
10.2.4. RNA Synthesis Inhibitors
10.2.5. Mycolic Acid Inhibitors
10.2.6. Others
10.3. Spectrum Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.3.1. Broad-spectrum Antibiotics
10.3.2. Narrow-spectrum Antibiotics
10.4. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.4.1. Germany
10.4.2. UK
10.4.3. France
10.4.4. Spain
10.4.5. Italy
10.4.6. Russia
10.4.7. Poland
10.4.8. Rest of Europe
10.5. Europe Antibiotics Market – Opportunity Analysis Index, By  Drug Class, Action Mechanism, Spectrum, and Country, 2022-2028
10.6. Europe Antibiotics Market Dynamics – Trends
11. Asia-Pacific Antibiotics Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
11.1. By Drug Class Analysis 2017-2021 and Forecast 2022-2028by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
11.1.1. Cephalosporins
11.1.2. Penicillins
11.1.3. Fluroquinilones
11.1.4. Macrolides
11.1.5. Carbapenems
11.1.6. Aminoglycosides
11.1.7. Sulfonamides
11.1.8. Others
11.2. Action Mechanism Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.2.1. Cell Wall Synthesis Inhibitors
11.2.2. Protein Synthesis Inhibitors
11.2.3. DNA Synthesis Inhibitors
11.2.4. RNA Synthesis Inhibitors
11.2.5. Mycolic Acid Inhibitors
11.2.6. Others
11.3. Spectrum Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.3.1. Broad-spectrum Antibiotics
11.3.2. Narrow-spectrum Antibiotics
11.4. Country Analysis2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
11.4.1. Japan
11.4.2. China
11.4.3. India
11.4.4. ASEAN
11.4.5. Australia & New Zealand
11.4.6. Rest of Asia-Pacific
11.5. Asia-Pacific Antibiotics Market – Opportunity Analysis Index, By  Drug Class, Action Mechanism, Spectrum, and Country, 2022-2028
11.6. Asia-Pacific Antibiotics Market Dynamics – Trends
12. Latin America Antibiotics Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
12.1. By Drug Class Analysis 2017-2021 and Forecast 2022-2028by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
12.1.1. Cephalosporins
12.1.2. Penicillins
12.1.3. Fluroquinilones
12.1.4. Macrolides
12.1.5. Carbapenems
12.1.6. Aminoglycosides
12.1.7. Sulfonamides
12.1.8. Others
12.2. Action Mechanism Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.2.1. Cell Wall Synthesis Inhibitors
12.2.2. Protein Synthesis Inhibitors
12.2.3. DNA Synthesis Inhibitors
12.2.4. RNA Synthesis Inhibitors
12.2.5. Mycolic Acid Inhibitors
12.2.6. Others
12.3. Spectrum Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.3.1. Broad-spectrum Antibiotics
12.3.2. Narrow-spectrum Antibiotics
12.4. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Argentina
12.4.4. Rest of Latin America
12.5. Latin America Antibiotics Market – Opportunity Analysis Index, By  Drug Class, Action Mechanism, Spectrum, and Country, 2022-2028
12.6. Latin America Antibiotics Market Dynamics – Trends
13. Middle East and Africa Antibiotics Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
13.1. By Drug Class Analysis 2017-2021 and Forecast 2022-2028by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
13.1.1. Cephalosporins
13.1.2. Penicillins
13.1.3. Fluroquinilones
13.1.4. Macrolides
13.1.5. Carbapenems
13.1.6. Aminoglycosides
13.1.7. Sulfonamides
13.1.8. Others
13.2. Action Mechanism Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.2.1. Cell Wall Synthesis Inhibitors
13.2.2. Protein Synthesis Inhibitors
13.2.3. DNA Synthesis Inhibitors
13.2.4. RNA Synthesis Inhibitors
13.2.5. Mycolic Acid Inhibitors
13.2.6. Others
13.3. Spectrum Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.3.1. Broad-spectrum Antibiotics
13.3.2. Narrow-spectrum Antibiotics
13.4. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
13.4.1. Gulf Cooperation Council (GCC) Countries
13.4.2. Israel
13.4.3. South Africa
13.4.4. Rest of MEA
13.5. MEA Antibiotics Market – Opportunity Analysis Index, By  Drug Class, Action Mechanism, Spectrum, and Country, 2022-2028
13.6. MEA Antibiotics Market Dynamics – Trends
14. Competition Landscape 
14.1. Strategic Dashboard of Top Market Players
14.2. Company Profiles (Introduction, Financial Analysis, Action Mechanism& Service Offerings, Key Developments, Strategies, and SWOT Analysis)
14.2.1. Abbott Laboratories
14.2.2. Allergan Plc.
14.2.3. F. Hoffmann-La Roche Ltd.
14.2.4. GlaxoSmithKline plc
14.2.5. Merck & Co. Inc.
14.2.6. Mylan N.V.
14.2.7. Novartis International AG (Sandoz)
14.2.8. Pfizer Inc.
14.2.9. Sanofi
14.2.10. Teva Pharmaceutical Industries Ltd.
15. Research Methodology
16. Key Assumptions and Acronyms

ASIA PACIFIC OFFICE

Precision Business Insights, MIG 366, SAI PLAZA, 1st Floor, KPHB Colony, Hyderabad - 500072

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX